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Background: Mismatch negativity (MMN) is a measure of pre-attentive auditory information processing related
to change detection. Traditional scalp-level EEG methods consistently ﬁnd attenuated MMN in patients with
chronic but not ﬁrst-episode schizophrenia. In the current paper, we use a source-resolved method to assess
MMN and hypothesize that more subtle changes can be identiﬁed with this analysis method.
Method: Fifty-six ﬁrst-episode antipsychotic-naïve schizophrenia (FEANS) patients (31 males, 25 females, mean
age 24.6) and 64 matched controls (37 males, 27 females, mean age 24.8) were assessed for duration-, fre-
quency- and combined-type MMN and P3a as well as 4 clinical, 3 cognitive and 3 psychopathological measures.
To evaluate and correlate MMN at source-level, independent component analysis (ICA) was applied to the
continuous EEG data to derive equivalent current dipoles which were clustered into 19 clusters based on cortical
location.
Results: No scalp channel group MMN or P3a amplitude diﬀerences were found. Of the localized clusters, several
were in or near brain areas previously suggested to be involved in the MMN response, including frontal and
anterior cingulate cortices and superior temporal and inferior frontal gyri. For duration deviants, MMN was
attenuated at the right superior temporal gyrus in patients compared to healthy controls (p=0.01), as was P3a
at the superior frontal cortex (p= 0.01). No individual patient correlations with clinical, cognitive, or psy-
chopathological measures survived correction for multiple comparisons.
Conclusion: Attenuated source-localized MMN and P3a peak contributions can be identiﬁed in FEANS patients
using a method based on independent component analysis (ICA). This indicates that deﬁcits in pre-attentive
auditory information processing are present at this early stage of schizophrenia and are not the result of disease
chronicity or medication. This is to our knowledge the ﬁrst study on FEANS patients using this more detailed
method.
1. Introduction
Schizophrenia is a mental illness characterized by positive symp-
toms (e.g., auditory hallucinations, delusions), negative symptoms (e.g.,
ﬂattening of aﬀects, social isolation), and cognitive deﬁcits (e.g. deﬁcits
in attention and memory). The underlying causes of schizophrenia are
of both genetic and environmental origin, with current models invol-
ving disturbances in early information processing, dysregulation of
dopamine, abnormal N-methyl-D-aspartate (NMDA) receptor func-
tioning and disruptions of connectivity (Baumeister and Francis, 2002;
Friston et al., 2016; Javitt et al., 2012; Olney et al., 1999).
One measure thought to index early information processing is
mismatch negativity (MMN), a pre-attentive mismatch between cov-
ertly expected and received auditory input. MMN can be obtained using
an unattended auditory oddball paradigm in which deviant tones are
interspersed among common standard tones, commonly diﬀering from
them either in terms of duration, frequency or intensity. MMN can be
recorded using both electroencephalography (EEG) and magnetoence-
phalography and is identiﬁed in the event-related potential (ERP) dif-
ference between ERPs time locked to onsets of deviant and standard
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tones, respectively. In the traditional method this response diﬀerence is
measured at one (usually frontocentral Fz or FCz) or across a few scalp
channels. MMN is a frontocentral scalp negative deﬂection peaking
between 100 and 250ms post-stimulus that is polarity-reversed (posi-
tive-going) on the scalp at electrode channels near the mastoids. Since
its ﬁrst description by Näätänen (1978), the MMN size and latency has
been used extensively to study brain auditory processing mechanisms
(reviewed in Näätänen et al., 2007). MMN is usually followed by a peak
sometimes referred to as P3a, a midfrontal positive peak between 250
and 300ms thought to index involuntary attentional reorientation to-
wards the deviant stimulus (Escera et al., 1998).
Several brain regions have been implicated in the generation of
MMN, including the auditory cortex, superior temporal gyrus, inferior
frontal gyrus, frontal cortex, anterior cingulate cortex and insula
(Gaebler et al., 2015; Giard et al., 1990; Waberski et al., 2001). Rissling
et al. (2014, discussed below) reported contributions from at least 6
cortical areas to the MMN complex recorded from the scalp. Further-
more, there is evidence that the supratemporal sources are active
~10–20ms earlier than the frontal sources (Fulham et al., 2014; Kim
et al., 2016; Rinne et al., 2000). For frequency deviants, some studies
have described an earlier component at 90–120ms post-stimulus,
thought to originate in the superior temporal gyrus, while the following
MMN originates in the inferior frontal gyrus (Doeller et al., 2003; Opitz
et al., 2002).
MMN has been described in terms of predictive coding (Garrido
et al., 2007a; Wacongne et al., 2012), and this idea is supported by data
(Powers et al., 2017). In the predictive coding theory, the brain is or-
ganized hierarchically, with higher-order stimulus event processing
levels sending predictions to lower levels. When the presentation of a
new stimulus does not match its prediction, a MMN response (indexing
prediction error) is generated at the lowest processing level and sent
upwards in the hierarchy, and this mismatch signalling is involved in
updating the predictive model. The auditory cortex, superior temporal
gyrus and inferior frontal gyrus are regarded as input regions for the
predictive coding model of the MMN response (Garrido et al., 2007b;
Lieder et al., 2013; Wacongne et al., 2012; Winkler, 2007).
MMN was ﬁrst linked to schizophrenia in 1991 when Shelley et al.
found that chronic schizophrenia patients had attenuated duration de-
viant MMN (Shelley et al., 1991). Today, attenuated frequency- and
duration deviant MMN is consistently found in chronic schizophrenia
and has been suggested as a standard biomarker for the disease (re-
viewed in Näätänen and Kähkönen, 2009; Light and Swerdlow, 2015).
In chronic schizophrenia, MMN has been associated with cognitive
impairment (Baldeweg et al., 2004), Global Assessment of Functioning
(GAF) and patients' level of independence (Light and Braﬀ, 2005), so-
cial cognition and functioning (Wynn et al., 2010), impaired executive
functioning (Toyomaki et al., 2008), and positive symptom scores
(Kärgel et al., 2014).
It has not, however, been well-established whether MMN is atte-
nuated in ﬁrst-episode antipsychotic-naïve schizophrenia (FEANS) pa-
tients, let alone ﬁrst-episode schizophrenia (FES). A recent meta-ana-
lysis on 14 studies of MMN in FES concluded that the eﬀect-size of
MMN attenuation is small and might be inﬂuenced by antipsychotic
medication (Haigh et al., 2017). In a recent study from our group we
did ﬁnd attenuated MMN using a dichotic selective attention paradigm
in FEANS patients, but no attenuation using a standard MMN paradigm
(Oranje et al., 2017).
The reason why MMN attenuation is not found in FES and FEANS
patients could be that the neuropathological changes causing MMN
attenuation (e.g. NMDA-receptor dysfunction (Javitt et al., 1996)) are
not yet present at this early stage of the disease or are present only in a
subgroup of patients. Alternatively, these changes could be present, but
only locally or to a degree too small for the deﬁcits to be measured by
the more traditional methods. The activity measured at a single elec-
trode channel (or mean signal across a location-based channel group)
sums not just potentials from the nearest underlying cortex but also
from potentials generated in many places in cortex. Unfortunately, this
is usually ignored in the literature, while studies of the speciﬁc, un-
derlying sources of MMN are usually not considered, whether or not
they report positive results.
Recently, a method for analysing ERP data based on independent
component analysis (ICA) decomposition applied to the continuous
(unaveraged) EEG data has been developed and applied to duration
deviant MMN modelling and measurement in chronic schizophrenia
patients (Makeig et al., 1996; Rissling et al., 2014). By clustering the
resulting independent component (IC) processes according to estimated
3-D locations of their equivalent current dipole models (Nunez and
Srinivasan, 2006) in a template head model, the eﬀective cortical
sources summing to produce scalp ERP features can be identiﬁed and
evaluated (Makeig et al., 2004; Makeig et al., 2002).
Using this methodology, Rissling et al. (2014) focused on six spa-
tially distinct IC process clusters contributing the most to the MMN and
P3a evoked response peaks and showed that these correlated sig-
niﬁcantly with functional measures including GAF and negative and
positive symptom scores in their patient group of medicated chronic
schizophrenia patients. They found attenuated duration deviant MMN
and P3a amplitudes in four of the six spatial IC clusters and found as-
sociations between several functional measures and the amplitude and
latency of MMN, P3a and RON (the subsequent ‘re-orienting negativity’
peak in the deviant-standard response diﬀerence wave) at the source
level, correlations that were not signiﬁcant using measures of the same
diﬀerence wave at a frontocentral (Fz to average reference) scalp
channel.
We previously reported no MMN or P3a attenuation in a relatively
large group of FEANS patients based on scalp recorded amplitudes
(Düring et al., 2015). Here we report whether MMN and P3a based on a
source-resolved approach provides further insight in this partly the
same group of patients. We evaluate frequency-, duration- and com-
bined- (frequency and duration) deviant based MMN and P3a features
at the eﬀective source level and correlate them with clinical, cognitive
and psychopathological measures. We test whether by using this
source-resolved approach we might disentangle the underlying gen-
erators of the scalp-recorded MMN and thereby identify subtle changes
in a patient group that is antipsychotic-naïve and not (much) inﬂuenced
yet by disease progress.
2. Materials and methods
2.1. Participants
The data used in this study is part of the Pan European
Collaboration Antipsychotic-Naive Studies (PECANS), a large cohort of
FEANS patients and matched controls examined with an extensive test
battery including cognitive and electrophysiological measures, mag-
netic resonance imaging and single-photon emission computed tomo-
graphy. In the current study, baseline data from the cognitive and
electrophysiological test battery were analysed. A part of the current
sample was previously analysed using a more traditional method and
published by Düring and colleagues (Düring et al., 2015). Patients and
controls from the same cohort partially overlap with those presented in
previous publications on other modalities (Bak et al., 2017; Düring
et al., 2015; Düring et al., 2014).
The study was conducted in accordance with the Declaration of
Helsinki II and was approved by the Danish National Committee on
Biomedical Research Ethics (H-D-2008-088) with clinical trials identi-
ﬁer: NTC01154829. Signed informed consent was provided by all par-
ticipants.
The total sample of the PECANS study was 69 FEANS patients and
67 healthy controls matched on age, gender and parental socio-
economic status. Of these, 56 FEANS patients and 64 healthy controls
had baseline EEG data from the MMN paradigm and were included in
this current study. The main reasons for participants' missing baseline
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EEG data were related to the need to start treatment or patients with-
drawing after initial acceptance. All included patients met the ICD-10
criteria for schizophrenia (n=55) or schizoaﬀective disorder (n=1).
None of the healthy controls had any previous or current mental health
issues and no known ﬁrst-degree relatives with mental health disorders.
Neither patients nor healthy controls had participated in psychophy-
siological studies before. Somatic illness was excluded through physical
examination of the patients. Further exclusion criteria were previous
impact-related unconsciousness, organic brain damage or disease,
substance dependency, known intellectual disability (IQ < 70), dis-
eases or processes contraindicated with amisulpride treatment (e.g. al-
lergy, prolactin-producing tumour), as well as involuntarily treatment
or treatment under judicial ruling. Substance use was not an exclusion
criterion, but its extent and type were noted. Urine samples were col-
lected to screen for benzodiazepine, cannabis, and central stimulant
use.
2.2. Clinical, cognitive and psychopathological measures
All participants were tested with a comprehensive neurocognitive
test battery including measures from the Cambridge
Neuropsychological Test Automated Battery (CANTAB, (Robbins et al.,
1994)), the Brief Assessment of Cognition in Schizophrenia (BACS,
(Keefe et al., 2004)), the Wechsler Adult Intelligence Scale III (WAIS III,
(Wechsler, 1997)), as well as the Danish Adult Reading Test (DART,
(Nelson and O'Connell, 1978)). All tests were administered by trained
research personnel.
From the extensive number of variables we choose a priori to include
only cognitive measures similar to those found to be associated with
MMN and P3a in the study by Rissling et al. (2014). DART was used to
assess premorbid intelligence (similar to the Wide Range Achievement
Test (WRAT3)). Number of correct responses from the Digit Sequencing
task from the BACS battery was included to mirror the Letter Number
Sequencing Test. Number of errors at the extradimensional set shifting
stage from the Intra−/Extradimensional Set Shift test (IED) from
CANTAB was included to assess perseveration (similar to perseverative
errors from the Wisconsin Card Sorting Test (WCST)). The patients'
daily function and symptom severity was assessed with the Social and
Occupational Functioning Assessment Scale (SOFAS, (Rybarczyk,
2011)) (similar to the Scale of Functioning (SOF, (Rapaport et al.,
1996))) and the Global Assessment of Function (GAF, (Hall, 1995))
divided in GAF functional and -social respectively. Severity of symp-
toms was assessed with the positive and negative syndrome scale
(PANSS) interview (Kay et al., 1988) similar to the Scale for the As-
sessment of Negative and Positive Symptoms (SANS, SAPS, (Andreasen,
1989)).
2.3. EEG processing
The following section is a brief description of the processing. For a
full description, see Supplementary Material A – Electrophysiology
Methods.All subjects were examined using the Copenhagen
Psychophysiological Test Battery (CPTB) (Oranje and Glenthøj, 2014).
EEG was recorded with BioSemi hardware (Amsterdam, Netherlands).
The paradigm consisted of four stimulus types: Standard tone, Fre-
quency deviant tone, Duration deviant tone and Combined (frequency
and duration deviant) tone.
All data processing and analysis was performed in MATLAB R2016b
(MATLAB and Statistics Toolbox Release 2016b, The MathWorks, Inc.,
Natick, Massachusetts, United States) and the MATLAB toolbox
EEGLAB (Delorme and Makeig, 2004). For each subject, the raw con-
tinuous Biosemi EEG data with associated channel locations was im-
ported re-referenced to average reference, and downsampled to 250 Hz.
A high-pass ﬁlter with ﬁnite impulse response (FIR) with pass-band
edge at 1 Hz (0.5 Hz @-6 dB, ﬁlter order 1650), was applied to improve
stability of data to facilitate ICA decomposition (Winkler et al., 2015).
The data was then semi-automatically cleaned of bad channels and
noisy segments using built-in EEGLAB tools.
The preprocessed continuous EEG data was then analysed using
Adaptive Mixture Independent Component Analysis (AMICA) (Palmer
et al., 2008). After ICA, each dataset had the same number of in-
dependent components (ICs) as the rank of the data matrix after
channel rejection, giving in total 7489 ICs — 4024 ICs for controls and
3465 ICs for patients (no signiﬁcant diﬀerence between groups,
χ2=0.033, p=0.86).
For each IC, the best-ﬁtting equivalent current dipole (ECD) in
Talairach space was computed using “DIPFIT” version 2.3, an EEGLAB
native plug-in based on FieldTrip (Oostenveld et al., 2011), another
open-source software environment for advanced analysis of EEG data.
We used a boundary element model (BEM) composed of three 3-D
surfaces (skin, skull and cortex) extracted from the Montreal Neurolo-
gical Institute (MNI) template head model with standard International
10–20 System electrode locations compatible with the Biosemi elec-
trode cap.
Before epoching, a ﬁnite impulse response (FIR) ﬁlter with pass-
band edge at 30 Hz (33.75 Hz @ -6 dB, ﬁlter order 110) was applied to
remove high-frequency noise.
Each dataset was then epoched according to the four stimulus types
from −1 to 2 s relative to stimulus onset. On average, for each subject
1681 epochs were available (SD, 237). Each epoch was baseline-cor-
rected using a reference interval from−100 to 0ms relative to stimulus
onset as baseline.
Finally, the data was cleaned from artefacts using two separate
methods: residual variance and clustering (see supplementary methods
A for full description).
2.4. Clustering and ERP measures
Equivalent current dipoles (ECDs) for brain-based eﬀective sources
(N=2387 ECDs; mean, 19.9 per subject (SD, 6.3); range 5–36) were
clustered using K-means clustering based on ECD location in Talairach
space. We chose to identify 19 clusters as each subject would then
contribute on average one independent component (IC) per cluster,
similar to Rissling et al. (2014). One additional cluster contained ICs
with outlier ECDs, deﬁned as being further than 3 standard deviations
from any of the 19 cluster centroids. This cluster (N=79 ECDs; 59
unique subjects; mean, 0.66 per subject (SD, 0.76); range, 0–3) was
excluded from further analysis.
Diﬀerence-ERP waveforms were derived for the frequency-, dura-
tion- and combined-type deviants: the deviant minus standard response
diﬀerence for each subject IC and across-subjects IC cluster. Grand-
average cluster MMN and P3a measures could then be derived.
Because stimulus onset asynchrony ranged from 300 to 500ms, we
could not, as in Rissling et al. (2014), reliably analyse the re-orienting
negativity which occurs at 400 to 600ms (Schröger and Wolﬀ, 1998).
For subjects having more than one IC in a cluster, we used the mean
of these components' ERP waveforms in subsequent analyses of these
subjects.
To obtain the latency intervals for measuring MMN and P3a am-
plitudes and peak latencies, we plotted the whole-sample grand average
deviant-standard diﬀerence waveform of the data summing all clus-
tered ‘brain’ IC projections to electrode channel FCz for each of the
three deviant types (Fig. 1). The scoring intervals were identiﬁed as the
latencies of the grand average MMN voltage minimum and the P3a
voltage maximum +/− 50ms, similar to other studies (Atkinson et al.,
2012; Salisbury et al., 2016). MMN mean amplitude was calculated as
mean voltage in the window surrounding the identiﬁed peak +/−
20ms, similar to Rissling et al. (2014).
MMN for the frequency- and combined-type deviants exhibited two
negative-going peaks thereby increasing the size of the MMN amplitude
measurement window. Each subject's MMN and P3a mean and peak
amplitudes and corresponding latencies were selected based on the
M. Randau, et al. NeuroImage: Clinical 22 (2019) 101760
3
minimum or, for polarity-reversed clusters, maximum peak within the
measurement window.
2.5. Statistical analysis
2.5.1. Source location measures
For each cluster, we tested for a signiﬁcant diﬀerence in occupation
by FEANS patients and healthy controls using a permutation test where
group memberships were permuted randomly 100,000 times. The p-
value for each cluster was expressed as the proportion of these per-
mutations in which the (permuted) cluster ratio of FEANS patients and
healthy controls were equal to or more extreme than the observed ratio.
2.5.2. Response attenuation measures
2.5.2.1. Scalp channel-level measures. To enable comparison of our
source-resolved approach with that of the more traditional scalp
channel-based method, group diﬀerences using the summed ‘brain’ IC
data back-projected to the FCz channel for each of the three deviant
types were tested using permutation tests.
2.5.2.2. Source-level measures. The main aim of the current study was
to evaluate MMN and P3a attenuation at the cortical source level to
search for subtle changes in FEANS patients not usually detectable with
the more traditional methods. A previous application of this method
found attenuation at six distinct sources for duration deviants in a
group of medicated and chronically ill schizophrenia patients (Rissling
et al., 2014). Therefore, our a priori analysis choices were to test
duration deviant MMN and P3a attenuation in these previously
identiﬁed sources: clusters centred in or near anterior cingulate,
dorsal mid-cingulate, medial orbitofrontal, ventral mid-cingulate, R
inferior frontal and R superior temporal cortical areas. Group
diﬀerences for these six clusters were tested for both MMN and P3a
peak and mean amplitude using permutation tests. Post hoc, any
signiﬁcant ﬁndings were then explored in an ANOVA approach to see
if the result was inﬂuenced by gender or age. Further, the summed
‘brain’ IC data back-projected to channels corresponding in location to
clusters with signiﬁcant group diﬀerences were also tested using
permutation tests.
Post hoc the remaining clusters with mean triphasic waveforms ex-
hibiting MMN and P3a peaks at expected latencies were tested for peak
and mean amplitude as well as peak latency for all three deviant types.
Bonferroni-Holm was used to account for multiple comparisons (270
measures= 15 clusters * 3 – min/max, mean and peak latency * 3
deviants * 2 peaks – MMN and P3a).
2.5.3. Correlation measures
A priori Spearman's non-parametric correlation coeﬃcients were
used to test the associations identiﬁed by Rissling et al. (2014) between
source-level duration MMN and P3a peak and mean amplitude and
peak latency and the clinical, cognitive and psychopathological mea-
sures. These were: medial orbitofrontal P3a amplitude with SOF, SANS,
and SAPS and P3a peak latency with EDS errors; R inferior frontal MMN
amplitude with DART and Digit Sequence and MMN and P3a peak la-
tency with EDS errors.
Post hoc Spearman's non-parametric correlation coeﬃcients were
used in an exploratory approach to examine the correlation between all
ten clinical, cognitive and psychopathological measures and MMN and
P3a for all three deviants for all clusters exhibiting triphasic curves as
well as the back projected ‘traditional’ method with MMN and P3a in
the relevant latencies (Fig. 2). Bonferroni-Holm was used to account for
multiple comparisons (2880 measures= 16 EEG measures (15 clusters
+ the ‘traditional’ method) * 10 measures * 3 – min/max, mean and
latency * 3 deviants * 2 peaks – MMN and P3a).
3. Results
3.1. Location
Fig. 2 shows whole-sample (patients and controls) cluster grand
average IC diﬀerence waves for the three deviant types for each of the
Fig. 1. Whole-sample grand average diﬀerence waveform summing all clustered IC projections to electrode channel FCz for each deviant type.
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19 clusters. Sources directly corresponding to those also found by Ris-
sling were: anterior cingulate cortex, medial orbitofrontal cortex, R
inferior frontal gyrus and R superior temporal gyrus. One cluster
(ventral mid-cingulate cortex) was not found in this study. Another
cluster (dorsal mid-cingulate cortex) corresponded to two clusters
identiﬁed in this study. These two clusters were closer to the cortex; we
interpreted their anatomical region as superior frontal gyrus and pre-
central gyrus. For all three deviants, 9 of the remaining 13 clusters
exhibited a triphasic wave with MMN and P3a peaks at expected la-
tencies. Four clusters (medial frontal, medial inferior and superior vi-
sual and R anterior parietal cortices) did not show a triphasic wave-
form. The ratio of contributing FEANS patients to healthy controls was
signiﬁcantly diﬀerent from random expectation for the cluster at L su-
perior temporal gyrus only (p=0.03), which included fewer FEANS
subject (see Fig. 2 for p-values).
3.2. Attenuation
3.2.1. Scoring windows
For frequency deviants, MMN and P3a intervals were 78–206ms
and 186–286ms respectively, for duration deviants, 150–250ms and
218–318ms, and for combined-type deviants 74–238ms and
202–302ms respectively (Fig. 1).
3.2.2. Scalp channel-level measures
Similar to our previous paper using the more traditional method at
electrode FCz and based on part of the current subject population
(Düring et al., 2015), we found no group diﬀerences in MMN or P3a
amplitude measures for any of the three deviants.
Post hoc analysis of channel T8 located outside the cluster at right
superior temporal gyrus (see below) revealed no group diﬀerences in
MMN or P3a amplitude measures for any of the three deviants
(Table 1).
3.2.3. Source-level measures
Group comparison of duration deviant MMN and P3a for the six a
priori chosen clusters revealed signiﬁcantly smaller MMN peak
(p=0.03) and mean (p=0.01) amplitude for FEANS patients com-
pared to controls for the right superior temporal gyrus cluster.
Additionally, for the superior frontal gyrus cluster, P3a peak (p=0.01)
but not mean amplitude was signiﬁcantly smaller in FEANS patients
than in controls. These results were not aﬀected by age or gender. None
of the other four clusters exhibited signiﬁcantly diﬀerent group
diﬀerences to duration deviants (see also Table 2 and Fig. 3).
Post hoc analysis of the remaining 9 clusters for each of the three
deviant types indicated several signiﬁcant group diﬀerences, but none
of these survived the Bonferroni-Holm corrections for multiple com-
parisons (see Supplementary Material B – Additional Data, Table S1).
3.3. Correlation
None of the correlations between clinical, cognitive or psycho-
pathological measures with duration deviant MMN and P3a amplitude
measures or peak latency reported by Rissling et al. (2014) were found
to be signiﬁcant in the current sample: medial orbitofrontal P3a am-
plitude with SOFAS (p=0.26), PANSS positive (p=0.16), PANSS ne-
gative (p=0.35) and P3a latency with EDS errors (p=0.89); R inferior
frontal MMN amplitude with DART (p=0.12) and Digit Sequence
(p=0.73) and MMN and P3a latency with EDS errors (p=0.24 and
0.19 respectively).
Post hoc analysis revealed 143 signiﬁcant correlations for the three
deviants, but none of these survived the Bonferroni-Holm corrections
for multiple comparisons (see Supplementary Material B – Additional
Data, Table S2).
4. Discussion
4.1. General
Here independent component analysis (ICA) was used to evaluate
MMN and P3a amplitude measures at the cortical source level in FEANS
patients and to correlate these with clinical, cognitive and psycho-
pathological measures. This is to our knowledge the ﬁrst study on this
patient group using this source-resolved approach. Although no group
diﬀerence in MMN or P3a amplitudes was found at the scalp channel
level, the ICA-decomposed data showed signiﬁcantly attenuated dura-
tion deviant MMN in the right superior temporal region as well as
signiﬁcantly attenuated duration deviant P3a amplitude in the superior
frontal region in patients compared to healthy controls. No a priori
deﬁned correlations to behavioural or clinical scores were found to be
signiﬁcant. Further, the post hoc correlations between either MMN or
P3a at sources with relevant waveforms and the 3 cognitive (DART,
Digit Sequence, EDS errors), 3 psychopathological (GAF functional and
-social, SOFAS), and 4 clinical measures (PANSS total, −positive,
−negative and -general) did not survive corrections for multiple com-
parisons. Our ﬁndings support that MMN and P3a attenuation in schi-
zophrenia are associated with early disease-related changes in supra-
temporal and frontal brain regions and are not the result of medication
or chronicity.
4.2. Cortical source locations
The spatial distribution of the identiﬁed sources are in line with
previous MMN source localisation studies using other modalities
Table 1
Participants. Group diﬀerences were tested by independent two-sample t-tests
or Chi-Square tests (gender).
FEANS patients Healthy controls p
n 56 64 0.83
Age 24.6 (5.75) 24.8 (5.62) 0.86
Gender (M/F) 31/25 37/27 0.71
DART 21.0 (9.27) 22.9 (6.51) 0.21
Digit Sequence 19.8 (4.64) 22.6 (3.68) <0.001
EDS errors 10.5 (10.7) 6.15 (7.56) 0.014
GAF functional 41.3 (10.8) – –
GAF social 40.0 (9.79) – –
PANSS total 83.3 (16.3)
PANSS positive 20.4 (4.22) – –
PANSS negative 21.2 (7.30) – –
PANSS general 41.8 (8.65) – –
SOFAS 42.3 (10.6) – –
DART=Danish Adult Reading Test. EDS errors= Errors made at the extra-
dimensional shift stage, CANTAB IED Test. Digit Sequence=Number of correct
responses, BACS Digit Sequencing Task, PANSS=Positive and Negative
Syndrome Scale. GAF=Global assessment of function. SOFAS= Social and
occupational functioning assessment scale.
P-values< 0.05 are in bold.
Table 2
P-values for group diﬀerences in amplitude measures of duration deviant re-
sponse diﬀerences at the six a priori chosen clusters.
Cluster MMN P3a
Max/Min Mean Max/Min Mean
1 - Anterior cingulate 0.83 0.37 0.51 0.39
11 - Medial orbitofrontal 0.34 0.38 0.36 0.34
13 - Precentral 0.86 0.77 0.18 0.71
14 - R inferior frontal 0.37 0.98 0.97 0.82
17 - R superior temporal 0.03 0.01 0.26 0.32
19 - Superior frontal 0.18 0.74 0.01 0.62
P-values< 0.05 are in bold.
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(functional magnetic resonance imaging, current source density) in-
dicating contributing sources in bilateral superior temporal gyri, ante-
rior cingulate cortex, and frontal cortical areas (including inferior
frontal gyrus) (Gaebler et al., 2015; Kim et al., 2016; Rissling et al.,
2014). In our data, triphasic response-diﬀerence waveforms in parietal
and visual source regions indicate more widespread event-related brain
activity during MMN generation. Activity in these regions has also been
found in other MMN source-localizing studies (Fulham et al., 2014;
MacLean et al., 2015).
An unresolved question is the distribution of subjects within the
clusters. While only the cluster in and near left superior temporal gyrus
showed a signiﬁcant diﬀerence in group occupancy, not all subjects
contributed to each cluster. There could be several reasons for this, such
as topological diﬀerences in cortical distribution or orientation giving
diﬀerent dipole orientations and locations in diﬀerent subjects, diﬀer-
ences in auditory processing strategies between subjects, or diﬀering
numbers of degrees of freedom available for ‘brain’ ICs because of
diﬀerences in artefact complexity across subjects. Signiﬁcantly more ICs
were removed as artefactual for patients, likely reﬂecting the presence
of more varied non-brain artefacts in patient data.
4.3. Attenuation
By applying independent component analysis decomposition to EEG
data from an MMN paradigm to evaluate MMN and P3a amplitude at a
cortical source level, we can for the ﬁrst time demonstrate that FEANS
patients exhibit attenuated duration deviant MMN peak and mean
amplitude in the right superior temporal region (containing right au-
ditory cortex) as well as an attenuated duration deviant P3a peak am-
plitude in the superior frontal region compared to healthy controls.
Our results are in line with other studies reporting attenuated
duration- but not frequency deviant MMN peak amplitude in the early
stages of schizophrenia (Näätänen and Kähkönen, 2009; Nagai et al.,
2013). The ﬁnding of attenuated MMN in the auditory cortex is in line
with other studies reporting reduced activation of the right (Fulham
et al., 2014; Perrin et al., 2017) or left (Solís-Vivanco et al., 2014)
auditory cortex in schizophrenia patients during MMN generation.
An attenuated MMN amplitude was not found in FEANS patients
relative to controls at our other investigated source regions, indicating
that relevant neuropathological changes are subtle or localized to su-
pratemporal and frontal regions at this early stage of the disease, which
is consistent with literature (Cobia et al., 2012). The MMN response in
the anterior cingulate cortex was not signiﬁcantly attenuated in our
patient group, while it was in chronic schizophrenia patients in the
study of Rissling et al. (2014). Whether this progression is due to
chronicity, treatment, or increased numbers of psychotic episodes
cannot be determined from the data.
There remains hope for developing deviant-tone response diﬀer-
ences including MMN into biomarkers for schizophrenia. Our results
showing that at least one source of MMN is attenuated (in response to
duration deviants) in FEANS patients, as well as one source of the en-
suing P3a response diﬀerence, adds one more piece to the puzzle. A
method for online EEG ICA evaluation has already been established
(Pion-Tonachini et al., 2015), potentially enabling future use of this
method in the clinic.
4.4. Correlation
The correlations between clinical, cognitive and psychopathological
measures and MMN and or P3a measures reported by Rissling et al.
(2014) for chronic schizophrenia patients were not replicated for this
ﬁrst-episode antipsychotic-naïve group of patients.
While cognitive deﬁcits have been shown to be stable across the
illness (Mesholam-Gately et al., 2009), FEANS patients may have better
Fig. 3. Duration MMN/P3a waveforms for FEANS
patients (red) and controls (blue) for a priori chosen
clusters. Images in top right corners show cluster-
mean projected scalp map (left) and equivalent di-
pole locations (right). Arrow indicates a signiﬁcant
group diﬀerence. Note the positive-going MMN for
cluster 17 (R superior temporal), contributing to the
MMN positivity at right temporal scalp sites. The
scale on the vertical axis is IC activation; the mag-
nitude at scalp channels (μV) is obtained by multi-
plying the IC activation with the inverse of the ICA
unmixing matrix. (For interpretation of the refer-
ences to color in this ﬁgure legend, the reader is
referred to the web version of this article.)
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global and social functioning than chronic patients. The lack of asso-
ciations might be explained by smaller variance in MMN and or P3a
peak amplitude measures and functional measures compared to chronic
schizophrenia patients, possibly due to medication eﬀects or progress of
the disease.
While none of our post hoc correlations survived Bonferroni-Holm
correction for multiple comparisons, several associations were sig-
niﬁcant before correction (see Supplementary Material B – Additional
Data, Table S2). Future studies could test directly the associations found
in this study and might also investigate whether, in view of apparent
measure dependencies in these data, a more sensitive method of cor-
recting for multiple comparisons might be applicable in further studies.
4.5. Strengths and limitations
The greatest strength of this study is the large sample of FEANS
patients. This allowed several thousand equivalent current dipoles,
each accounting for a brain eﬀective EEG source found by ICA de-
composition of the unaveraged data, to be sorted into large well-deﬁned
spatial clusters. While providing high temporal and welcome spatial
resolution, the ICA source separation and source clustering methods
employed here do not enable us to spatially distinguish auditory cortex
and superior temporal gyrus sources. Being able to distinguish between
these sources could reveal important mechanics of MMN generation.
It should be mentioned that even though all patients were anti-
psychotic-naïve, other forms of medication might have inﬂuenced our
ﬁndings.
The preprocessing pipeline used here followed up-to-date re-
commendations, however, EEG source localization is not ground truth.
The brain areas for the identiﬁed sources note the centroids of the
clusters and should not be seen as a speciﬁc point in the brain but rather
an area.
ICA and independent source localization and clustering tools are
still being improved. The requirement to pre-specify the number of
clusters and clustering measures to employ in computing IC-pair dis-
tances adds a user-related uncertainty to the method. We clustered on
ECD location alone to ensure spatially separable clusters. Including
other measures (e.g., ERP, scalp map and power spectrum) could po-
tentially increase the physiological coherence, at the possible cost of
spatial coherence.
A standard/deviant tone paradigm taking full advantage of the trial-
by-trial analysis approaches made possible by ICA decomposition might
give further insights. Although, to our knowledge, such a paradigm has
not yet been developed, it could for example involve longer recording
sessions, more variegated properties of deviants, and possibly separate
sessions for deviant types to better explore the cortical sources active in
the auditory deviance response network and their dynamic inter-
relationships.
5. Conclusion
Our study shows that localized MMN and P3a amplitude attenuation
in response diﬀerences between average event-related potentials
evoked by a nonattended stream of standard and occasional deviant
tones, respectively, can be identiﬁed in FEANS patients using a source-
resolved approach based on identiﬁcation of sources by independent
component analysis. Here, no a priori correlations between either MMN
or P3a and clinical, cognitive and psychopathological measures were
found, and none of the exploratory correlations survived correction for
multiple comparisons. Since there is evidence that these associations
are present in more chronic populations of schizophrenia patients, this
result may indicate that these associations develop gradually in the
disease process or are in some part eﬀects of medication.
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